On October 28, Bloomberg reported that in its IPO filing, Anthropic warned that its public advocacy for AI safety regulation and statements from executives could expose the company to risks such as government pressure and selective scrutiny. The document stated that even if other similarly situated companies are not treated equally, Anthropic could still become a target for specific government agencies, a risk associated with the company's multiple conflicts with the Trump administration: one stemming from disputes over the requirement for the U.S. Department of Defense to set safety limits when using its AI technology, and another related to disagreements over the safety and export controls of the Mythos model. The filing also indicated that future government interventions, export restrictions, and cybersecurity or biosafety incidents triggered by AI models could affect its product deployment, international expansion, and business growth. Furthermore, if the regulatory measures advocated by the company are implemented, compliance costs would rise, product development and release would be restricted, and its growth could slow down. Anthropic publicly submitted its S-1 filing on October 26, intending to list on Nasdaq under the ticker ANT.
All Comments